| The subtle balance between lipolysis and lipogenesis: a critical point in metabolic homeostasis C Saponaro, M Gaggini, F Carli, A Gastaldelli Nutrients 7 (11), 9453-9474, 2015 | 486 | 2015 |
| Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms C Saponaro, M Gaggini, A Gastaldelli Current diabetes reports 15, 1-13, 2015 | 168 | 2015 |
| Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease C Rosso, L Mezzabotta, M Gaggini, F Salomone, R Gambino, A Marengo, ... Hepatology 63 (1), 107-116, 2016 | 83 | 2016 |
| Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD I Pierantonelli, C Rychlicki, L Agostinelli, DM Giordano, M Gaggini, ... Scientific reports 7 (1), 12200, 2017 | 80 | 2017 |
| Not all fats are created equal: adipose vs. ectopic fat, implication in cardiometabolic diseases M Gaggini, C Saponaro, A Gastaldelli Hormone molecular biology and clinical investigation 22 (1), 7-18, 2015 | 69 | 2015 |
| Cytocompatibility evaluation of glycol-chitosan coated boron nitride nanotubes in human endothelial cells S Del Turco, G Ciofani, V Cappello, M Gemmi, T Cervelli, C Saponaro, ... Colloids and Surfaces B: Biointerfaces 111, 142-149, 2013 | 61 | 2013 |
| Interindividual heterogeneity of SGLT2 expression and function in human pancreatic islets C Saponaro, M Mühlemann, A Acosta-Montalvo, A Piron, V Gmyr, ... Diabetes 69 (5), 902-914, 2020 | 43 | 2020 |
| SGLT2 inhibition and glucagon secretion in humans C Saponaro, F Pattou, C Bonner Diabetes & metabolism 44 (5), 383-385, 2018 | 39 | 2018 |
| Tanycytes control hypothalamic liraglutide uptake and its anti-obesity actions M Imbernon, C Saponaro, HCC Helms, M Duquenne, D Fernandois, ... Cell metabolism 34 (7), 1054-1063. e7, 2022 | 38 | 2022 |
| Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals C Saponaro, S Sabatini, M Gaggini, F Carli, C Rosso, V Positano, ... Liver International 42 (11), 2418-2427, 2022 | 37 | 2022 |
| The GLP1R agonist liraglutide reduces hyperglucagonemia induced by the SGLT2 inhibitor dapagliflozin via somatostatin release C Saponaro, V Gmyr, J Thevenet, E Moerman, N Delalleau, G Pasquetti, ... Cell Reports 28 (6), 1447-1454. e4, 2019 | 35 | 2019 |
| The LIFE PERSUADED project approach on phthalates and bisphenol A biomonitoring in Italian mother-child pairs linking exposure and juvenile diseases C La Rocca, F Maranghi, S Tait, R Tassinari, F Baldi, G Bottaro, ... Environmental Science and Pollution Research 25, 25618-25625, 2018 | 19 | 2018 |
| A novel 2, 3-diphenyl-4H-pyrido [1, 2-a] pyrimidin-4-one derivative inhibits endothelial cell dysfunction and smooth muscle cell proliferation/activation S Del Turco, S Sartini, C Sentieri, C Saponaro, T Navarra, B Dario, ... European journal of medicinal chemistry 72, 102-109, 2014 | 19 | 2014 |
| The subtle balance between lipolysis and lipogenesis: a critical point in metabolic homeostasis. Nutrients 7 9453–9474 C Saponaro, M Gaggini, F Carli, A Gastaldelli | 16 | 2015 |
| The subtle balance between lipolysis and lipogenesis: a critical point in metabolic homeostasis. Nutrients. 2015; 7: 9453–74 C Saponaro, M Gaggini, F Carli, A Gastaldelli PUBMED, 0 | 10 | |
| The subtle balance between lipolysis and lipogenesis: a critical point in metabolic homeostasis. Nutrients 7 (11): 9453–9474 C Saponaro, M Gaggini, F Carli, A Gastaldelli | 9 | 2015 |
| Cardiometabolic risk and subclinical vascular damage assessment in idiopathic inflammatory myopathies: a challenge for the clinician S Barsotti, C Saponaro, M Gaggini, R Talarico, E Bianchini, N Di Lascio, ... Clin Exp Rheumatol 37 (6), 1036-43, 2019 | 8 | 2019 |
| The subtle balance between lipolysis and lipogenesis: a critical point in metabolic homeostasis. Nutrients. 2015; 7 (11): 9453–74 C Saponaro, M Gaggini, F Carli, A Gastaldelli | 8 | |
| Proglucagon-derived peptides expression and secretion in rat insulinoma INS-1 cells A Acosta-Montalvo, C Saponaro, J Kerr-Conte, JHM Prehn, F Pattou, ... Frontiers in Cell and Developmental Biology 8, 590763, 2020 | 7 | 2020 |
| Therapeutic agent for treatment of blood vessels C LA MOTTA, F DA SETTIMO PASSETTI, B Dario, S Sartini, G Basta, ... | 5 | 2013 |
